| Match | Type | Why |
|---|
| B effector cells in rheumatoid arthritis and experimental arthritis. | Academic Article |
Why?
|
| Destructive polyarthritis due to a group B streptococcus. | Academic Article |
Why?
|
| Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis. | Academic Article |
Why?
|
| Lyme arthritis presenting as acute septic arthritis in children. | Academic Article |
Why?
|
| 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. | Academic Article |
Why?
|
| 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. | Academic Article |
Why?
|
| Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. | Academic Article |
Why?
|
| Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis. | Academic Article |
Why?
|
| Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis. | Academic Article |
Why?
|
| Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models. | Academic Article |
Why?
|
| Imaging apoptosis in rheumatoid arthritis. | Academic Article |
Why?
|
| Genkwanin ameliorates adjuvant-induced arthritis in rats through inhibiting JAK/STAT and NF-?B signaling pathways. | Academic Article |
Why?
|
| The cellular source and target of IL-21 in K/BxN autoimmune arthritis. | Academic Article |
Why?
|
| Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. | Academic Article |
Why?
|
| B cells as effectors and regulators of sex-biased arthritis. | Academic Article |
Why?
|